| |
DaVinci Cafe Longevity Series - The Brain
|
| With Christin Glorioso (Founder/CEO, NeuroAge Therapeutics), Alex Colville (Longevity), Kazu Okuda (Neurotech), Allison Leopold (Pillsbury Winthrop). |
| Venue, 2550 Hanover St, Palo Alto |
|
Jun 04 (Wed) , 2025 @ 05:00 PM
| |
FREE |
|
|
|
|
|
|
|
|
| |
| DETAILS |
|
In a world driven by rapid & complex challenges, innovation thrives at the convergence of technologies.
By bringing together experts from different domain areas, we unlock new possibilities.
Welcome to DaVinci Caf, where thinkers, creators, & visionaries connect & collaborate.
Agenda
Date: June 4th
Address: 2550 Hanover Street | Palo Alto, CA 94304-1115
5:00 PM: check in & networking
5:30-6:30 PM: Panel discussion + Q&A
6:30-7:00 PM: networking
This event will include light appetizers, wine/beer & non-alcoholic beverages.
Our speakers
Moderator
Dr. Garrett Vygantas: Venture investor, CEO, serial entrepreneur.
User Uploaded Image
Garrett Vygantas, MD, MBA is Founder & Managing Partner of Riverine Ventures, a life science & healthcare dedicated venture capital firm. Trained as a physician & an experienced entrepreneur, Garrett provides strategic direction & valuable clinical & commercial networks as a Board Member or Advisor to Adventris Pharma, AEye Health, ArtiSight, CellFE, Ceria Therapeutics, Corsair Pharma, Eliksa Therapeutics, HealthBridge, Inflammatix, KeifeRx, Mediphage & Pieces Technologies.
With over 20 years, Garrett's expertise spans across biopharma, life sciences, healthcare, medtech & digital health investing & operations. Before founding Riverine Ventures, he has invested on behalf of The 4100 Group, OSF Healthcare, Jump Capital & Burrill & Co. As an operator, he served as Founding CEO of TherOptix, NewBridge Pharmaceuticals & Mitre Medical & Chief Business Officer of Corsair Pharma. At NewBridge, he & his team raised over $60M in financing & created $470M in nominal value.
Panel speakers:
1. Dr. Alex Colville: Investor in Longevity
User Uploaded Image
Dr. Alex Colville is the General Partner & cofounder of age1 alongside Laura Deming. age1 is the continuation of the first longevity-focused VC fund founded in 2011 by Laura (5 IPOs). Alex is an advisor & previously served as founding Chief of Staff of the Amaranth Foundation, a family office dedicated to advancing interventions to extend healthy human lifespan where he led investments into over 20 companies & supported philanthropic initiatives including AFAR & the TIME Initiative. Prior to working for family offices, Alex received a PhD in genetics at Stanford University studying rejuvenation & the biology of aging in Tom Rando's lab. During his PhD he consulted for the business development group at Maze Therapeutics & the scientific team at Rubedo Life Sciences.
2. Dr. Christin Glorioso: CEO & Co-founder, NeuroAge Therapeutics | Founder & Executive Director, Longevity Global
User Uploaded Image
Dr. Christin Glorioso is a neuroscientist, physician, & serial entrepreneur. She is co-founder & CEO of NeuroAge Therapeutics & Founder & Executive Director of the non-profit, Longevity Global. Christin completed her postdoctoral training at MIT & holds an MD & PhD in Neuroscience from the University of Pittsburgh School of Medicine.
3. Dr. Kazu Okuda
User Uploaded Image
Kazu Okuda, M.D. is a physician turned neurotechnology entrepreneur driven to improve mental health care. Previously, he was involved in clinical development, fundraising, & ultimately securing regulatory clearance & national insurance reimbursement for an AI-powered medical device at a Japanese med-tech startup. He then moved to the United States to found Universal Brain in 2022, tackling a fundamental gap in psychiatry: the routine measurement of brain function.Universal Brain's platform captures well-validated brain function measures, called event-related potentials (ERPs), that reflect core neural processes linked to depression & its treatment. By turning these EEGbased measures into a scalable, clinicready tool, he aims to make objective brainfunction testing a standard component of mentalhealth care to get better outcomes-starting with depression & expanding across psychiatric conditions.
4. Allison M. Leopold Tilley Partner at Pillsbury Winthrop Shaw Pittman LLP
User Uploaded Image
Allison Leopold Tilley is named one of the top Women Leaders in Tech Law by The Recorder for six consecutive years & hailed as the Technology Dealmaker of the Year by The Deal. Based in Silicon Valley, Allison advises technology companies, including on their formation, venture capital financings, multibillion-dollar M&As, public offerings, securities transactions, SPAC transactions & board governance.
About the hosts & sponsors:
Hosts: Davinci Cafe: Where thinkers, creators, & visionaries from every industry connect, collaborate, & shape the future. Find your tribe, your partners, & your inspiration.
Sponsors: Pillsbury Winthrop Shaw Pittman LLP: A global law firm focusing on the Tech, Energy, Financial, Real Estate & Construction, & Life Sciences industries.
Please note, this event may be photographed & filmed. Davinci Cafe reserves the right to use photographs & video from the event for marketing & communications purposes. By attending the event you consent to your image being used for these purposes.
To maintain the integrity of our peer collaboration & to respect venue capacity, we will not accommodate walk-ins or +1s for the event. Thank you in advance for your cooperation.
|
|
|
|
|
|
|
|
